Bristol-Myers Squibb: At 138 on the Fortune 500 list, BMS rose seven spots from the previous year. However, Pfizer's profit percentage fell by 47%, Fortune said, which explains the drop in the ranking. Johnson & Johnson: In the latest Fortune rankings, life science giant J&J ranked 37th on the list of 500 companies. Eli Lilly: Ranked 123rd on the list, Indianapolis-based Eli Lilly rose six spots from the previous year, thanks to a 7.4% increase in revenue.
Twenty pharmaceutical companies are included in the annual list that Fortune compiles to rank the 500 highest-earning American companies. With sales of its much-vaunted portfolio of hepatitis-related products falling, Gilead's revenues fell 15.2% from the previous year, causing the company to drop 23 places in the rankings. Zoetis: The last pharmaceutical company on the Fortune 500 list is Zoetis, an animal health company, based in New Jersey.